DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Share Price

Certificat

DE000ME3YSH0

Market Closed - Börse Stuttgart 12:42:32 29/06/2024 am IST
0.186 EUR +3.33% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-52.31%
1 month-52.31%
Date Price Change
28/24/28 0.186 +3.33%
27/24/27 0.18 -0.55%
26/24/26 0.181 +2.84%
25/24/25 0.176 -25.11%
24/24/24 0.235 -2.08%

Delayed Quote Börse Stuttgart

Last update June 29, 2024 at 12:42 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME3YSH
ISINDE000ME3YSH0
Date issued 21/11/2023
Strike 60 $
Maturity 20/09/2024 (82 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.46
Lowest since issue 0.129
Spread 0.008
Spread %4.04%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.09 USD
Average target price
83.43 USD
Spread / Average Target
+46.14%
Consensus